Screener
National Research Corporation NRC Q3 2026 earnings
Reported October 26, 2026 · After market close
Revenue$38.4MBeat by $2.6M
EPS$0.21Beat by $0.03
Revenue estimate$35.8M
EPS estimate$0.18
“We delivered a strong third quarter, with revenue up 11% year-over-year and sequential margin expansion. Our large customer went live on schedule, and several long-standing customers renewed under multi-year agreements, reinforcing the durability of our recurring-revenue base. As our expanding contract base converts into revenue, the operating leverage inherent in our model will translate into greater profitability and free cash flow over time, reinforcing our confidence in NRC Health's ability to create long-term shareholder value.”
Next report
Feb 2, 2027 (in 2 months)Revenue estimate$38.8M
EPS estimate$0.24
Valuation & ratios
Segments
By product
Versus estimates
Revenue
Q3 2026$38.4MBeat by $2.6M
Q2 2026$35.4MBeat by $492.0KQ1 2026$34.8MQ4 2025$35.2MQ3 2025$34.6MQ2 2025$34.0MDiluted EPS
FAQ
- When did National Research Corporation report Q3 2026 earnings?
- National Research Corporation (NRC) reported Q3 2026 earnings on October 26, 2026 after market close.
- What were National Research Corporation's Q3 2026 revenue and EPS?
- National Research Corporation reported revenue of $38.4M and eps of $0.21 for Q3 2026.
- Did National Research Corporation beat estimates in Q3 2026?
- Revenue beat the consensus estimate of $35.8M by $2.6M. EPS beat the consensus estimate of $0.18 by $0.03.
- How did National Research Corporation's Q3 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 11.0% from $34.6M a year earlier and eps declined 8.7% from $0.23.
- Where can I find National Research Corporation's Q3 2026 SEC filings?
- You can read the 8-K earnings release (0001437749-26-033639) and the 10-Q periodic report (0001437749-26-034887) directly on SEC EDGAR. The filing index links above go to sec.gov.
